Zwijnaarde, Belgium

Eric Lorent

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric Lorent

Introduction

Eric Lorent is a notable inventor based in Zwijnaarde, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic drugs. With a total of five patents to his name, Lorent's work focuses on addressing inflammatory and autoimmune diseases through innovative polypeptide designs.

Latest Patents

One of Lorent's latest patents involves nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP. This technology aims to provide a new type of drug for treating subjects suffering from inflammatory diseases. The polypeptides are characterized by containing at least four immunoglobulin single variable domains, with at least two binding to IL-13 and at least two binding to TSLP. Additionally, he has developed polypeptides targeting IL-6 and TNF-α, which are intended for treating inflammatory and autoimmune diseases, specifically rheumatoid arthritis. This disclosure also includes nucleic acids, vectors, and compositions that enhance the therapeutic potential of these polypeptides.

Career Highlights

Throughout his career, Eric Lorent has worked with prominent companies in the biotechnology sector, including Ablynx and Sanofi. His experience in these organizations has allowed him to refine his expertise in drug development and innovation. Lorent's work has been instrumental in advancing therapeutic options for patients with challenging health conditions.

Collaborations

Eric Lorent has collaborated with several professionals in his field, including Heidi Rommelaere and Ann Brigé. These partnerships have contributed to the successful development of his patented technologies and have fostered a collaborative environment for innovation.

Conclusion

Eric Lorent's contributions to biotechnology through his innovative patents and collaborations highlight his commitment to improving treatment options for inflammatory and autoimmune diseases. His work continues to pave the way for advancements in therapeutic drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…